Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colitis, Ulcerative × Loperamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2 Short Bowel Syndrome 1 Esophageal Squamous Cell Carcinoma 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Colitis, Ulcerative 1

Interventions

etrolizumab 4 Ringer's Lactate 1 Mesalamine 1 Loperamide 1 Injections 1 Infliximab 1 Hydroxyethyl Starch Derivatives 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02266849 2016-10-11

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Odense University Hospital

Phase 3 Terminated

Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms, Short Bowel Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡